senate Bill S3865A

2011-2012 Legislative Session

Provides that persons with clotting protein deficiencies who are otherwise eligible for certain health insurance programs shall have access to reimbursement for certain services

download bill text pdf

Sponsored By

Archive: Last Bill Status -


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

do you support this legislation?

You must fill out the form below in order to support or oppose this bill. X

You must login or fill out the fields below for the senator to have an accurate account of the support or opposition to this bill.

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.
Use this box to enter a message to your senator.

Actions

view actions (6)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jun 05, 2012 reported and committed to finance
Jan 04, 2012 referred to health
Jun 15, 2011 print number 3865a
amend (t) and recommit to finance
May 03, 2011 reported and committed to finance
Mar 08, 2011 referred to health

Votes

view votes

Jun 5, 2012 - Health committee Vote

S3865A
14
0
committee
14
Aye
0
Nay
1
Aye with Reservations
0
Absent
2
Excused
0
Abstained
show Health committee vote details

Health Committee Vote: Jun 5, 2012

aye wr (1)
excused (2)

May 3, 2011 - Health committee Vote

S3865
13
0
committee
13
Aye
0
Nay
4
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show committee vote details

Co-Sponsors

S3865 - Details

See Assembly Version of this Bill:
A6039A
Law Section:
Public Health Law
Laws Affected:
Amd §2510, Pub Health L; amd §369-ee, Soc Serv L

S3865 - Summary

Provides that persons with hemophilia and other clotting protein deficiencies who are otherwise eligible for the Child Health Plus or Family Health Plus program shall have access to reimbursement for outpatient blood clotting factor concentrates and other necessary treatments and services.

S3865 - Sponsor Memo

S3865 - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  3865

                       2011-2012 Regular Sessions

                            I N  S E N A T E

                              March 8, 2011
                               ___________

Introduced  by  Sen.  ROBACH -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend the public health law, the social services law  and  the
  insurance  law,  in relation to providing that persons with hemophilia
  and other clotting protein deficiencies who are otherwise eligible for
  the Child Health Plus,  Family  Health  Plus,  and  Healthy  New  York
  programs shall have access to reimbursement for outpatient blood clot-
  ting factor concentrates and other necessary treatments and services

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1.   Legislative findings. Hemophilia  is  a  rare  hereditary
bleeding disorder resulting from a deficiency in blood proteins known as
clotting factors.  Without an adequate supply of clotting factors, indi-
viduals  can experience prolonged bleeding following routine medical and
dental procedures, trauma, and a range  of  physical  activities.  Addi-
tionally,  individuals  with  hemophilia  often  experience  spontaneous
internal bleeding that can cause severe joint damage, chronic pain,  and
even death.
  Prior  to  the  1970s, individuals with hemophilia seldom lived beyond
the age of 30 years. Early treatment consisted of whole blood and plasma
transfusions at hospitals. These treatments were difficult, time consum-
ing and only minimally effective. The advent  of  commercially  prepared
blood  clotting  factors  in  the  1980s  represented a major advance in
treatment, both in terms of efficacy and convenience. Most  importantly,
these advances allowed for home infusion.
  In addition to hemophilia, there are several other disorders resulting
from  blood  protein  deficiencies. These include Von Willebrand Disease
(VWD), the most common bleeding disorder,  affecting  approximately  two
million  Americans.  Individuals  with  the severest form of VWD rely on
clotting factor treatments similar to those  used  by  individuals  with
hemophilia.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD09788-01-1

Co-Sponsors

S3865A (ACTIVE) - Details

See Assembly Version of this Bill:
A6039A
Law Section:
Public Health Law
Laws Affected:
Amd §2510, Pub Health L; amd §369-ee, Soc Serv L

S3865A (ACTIVE) - Summary

Provides that persons with hemophilia and other clotting protein deficiencies who are otherwise eligible for the Child Health Plus or Family Health Plus program shall have access to reimbursement for outpatient blood clotting factor concentrates and other necessary treatments and services.

S3865A (ACTIVE) - Sponsor Memo

S3865A (ACTIVE) - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 3865--A

                       2011-2012 Regular Sessions

                            I N  S E N A T E

                              March 8, 2011
                               ___________

Introduced  by  Sens. ROBACH, KRUEGER -- read twice and ordered printed,
  and when printed to  be  committed  to  the  Committee  on  Health  --
  reported  favorably from said committee and committed to the Committee
  on Finance -- committee discharged, bill amended, ordered reprinted as
  amended and recommitted to said committee

AN ACT to amend the public health law, the social services law  and  the
  insurance  law,  in relation to providing that persons with hemophilia
  and other clotting protein deficiencies who are otherwise eligible for
  the Child Health Plus or Family Health Plus programs shall have access
  to reimbursement for outpatient blood clotting factor concentrates and
  other necessary treatments and services

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.    Legislative  findings.  Hemophilia is a rare hereditary
bleeding disorder resulting from a deficiency in blood proteins known as
clotting factors.  Without an adequate supply of clotting factors, indi-
viduals can experience prolonged bleeding following routine medical  and
dental  procedures,  trauma,  and  a range of physical activities. Addi-
tionally,  individuals  with  hemophilia  often  experience  spontaneous
internal  bleeding that can cause severe joint damage, chronic pain, and
even death.
  Prior to the 1970s, individuals with hemophilia  seldom  lived  beyond
the age of 30 years. Early treatment consisted of whole blood and plasma
transfusions at hospitals. These treatments were difficult, time consum-
ing  and  only  minimally effective. The advent of commercially prepared
blood clotting factors in the  1980s  represented  a  major  advance  in
treatment,  both in terms of efficacy and convenience. Most importantly,
these advances allowed for home infusion.
  In addition to hemophilia, there are several other disorders resulting
from blood protein deficiencies. These include  Von  Willebrand  Disease
(VWD),  the  most  common bleeding disorder, affecting approximately two

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD09788-02-1

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.